Cardio-Oncology
Management of Toxicities in the Era of Immunotherapy
Springer Nature Switzerland
ISBN 978-3-030-97744-3
Standardpreis
Bibliografische Daten
eBook. PDF. Weiches DRM (Wasserzeichen)
2022
XIV, 122 p. 21 illus., 18 illus. in color..
In englischer Sprache
Umfang: 122 S.
Verlag: Springer Nature Switzerland
ISBN: 978-3-030-97744-3
Weiterführende bibliografische Daten
Das Werk ist Teil der Reihe: Medicine Current Clinical Pathology Medicine (R0)
Produktbeschreibung
The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells. In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC).
Autorinnen und Autoren
Produktsicherheit
Hersteller
Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg, DE
ProductSafety@springernature.com
BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS

